Skye Montoya

6PUBLICATIONS
62CO-AUTHORS
Cancer geneticsMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 18, 2025
XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance.

Tulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca

|Jul 12, 2024
Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition.

Sana Chaudhry, Felipe Beckedorff, Shaista Shabbir Jasdanwala

|Feb 01, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.

Skye Montoya, Jessie Bourcier, Mark Noviski

|Dec 23, 2023
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL).

Alexandra Chirino, Skye Montoya, Anita Safronenka

Pageof 1